rdf:type |
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0031928,
umls-concept:C0032743,
umls-concept:C0205195,
umls-concept:C0205851,
umls-concept:C0392756,
umls-concept:C0441767,
umls-concept:C0600210,
umls-concept:C0679199,
umls-concept:C1306673,
umls-concept:C1518411,
umls-concept:C1521721,
umls-concept:C1705535,
umls-concept:C2607943,
umls-concept:C2926606
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-2-8
|
pubmed:abstractText |
To examine the nodal (N+) vs extranodal (M+) staging in each of the International Germ Cell Consensus Classification Group (IGCCCG) subgroups in an audit of 437 patients treated in The Anglian Germ Cell Cancer Group, where chemotherapy was the primary management, as there is an increasingly earlier presentation of patients with less advanced disease who thus face potentially unnecessary treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1464-410X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
570-4
|
pubmed:meshHeading |
pubmed-meshheading:18257857-Adult,
pubmed-meshheading:18257857-Antineoplastic Agents,
pubmed-meshheading:18257857-Cohort Studies,
pubmed-meshheading:18257857-Humans,
pubmed-meshheading:18257857-Male,
pubmed-meshheading:18257857-Middle Aged,
pubmed-meshheading:18257857-Neoplasm Recurrence, Local,
pubmed-meshheading:18257857-Neoplasm Staging,
pubmed-meshheading:18257857-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:18257857-Pilot Projects,
pubmed-meshheading:18257857-Positron-Emission Tomography,
pubmed-meshheading:18257857-Prospective Studies,
pubmed-meshheading:18257857-Risk Factors,
pubmed-meshheading:18257857-Survival Analysis,
pubmed-meshheading:18257857-Testicular Neoplasms,
pubmed-meshheading:18257857-Tomography, X-Ray Computed,
pubmed-meshheading:18257857-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour.
|
pubmed:affiliation |
Oncology Center, Addenbrooke's Hospital, Cambridge, UK.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|